Therefore, to validate the function of PF403 in the NAMPT knockdown orthotopic glioma model, we established the model with shNAMPT-2 U87 cells and used the effective dose (6 mg/kg CAT3) for a treatment lasting 11 days (Fig. 8A). This evidence concerns the gene SLC7A3 and central nervous system cancer.